Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders

Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders

US Patent 9133235 · Granted Sep 15, 2015

Estimated economic value: $1,070,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body f2025
Neurotensinergic agonists and methods of using same preventing or treating pain2025
Piperidine derivatives as METTL3 inhibitors2024
Peptide macrocycles against Acinetobacter baumannii2024
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2023
Macrocyclic compounds and methods of preventing or treating pain2023
NK-3 receptor antagonists for therapeutic treatment of leptin-related disease2022
Peptide macrocycles against Acinetobacter baumannii2021
Matriptase inhibitors and uses thereof2021
Libraries of heteroaryl-containing macrocyclic compounds and methods of making a2021
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as2021
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2020